The probiotic journey, from discovery to health benefit substantiation

The global probiotics and microbiome therapeutics markets offer exciting opportunities, and both are expected to grow strongly in the coming years. Food (ingredient), probiotic, cosmetic and pharmaceutical companies are all looking for new ways to use the naturally occurring bacteria in and on our bodies, to meet the increasing customer demand.

NIZO helps companies to identify, grow, optimise, and substantiate the health benefits of probiotics and live biotherapeutic products (LBPs). We are the leading contract research organisation (CRO) in the discovery, screening and selection of these organisms and the substantiation of their health benefits, with over 78 years of experience.

Download our leaflet and uncover insights into:

• A passion for probiotics
• Building on expertise and technology:
  • State-of-the-art bioinformatics
  • Process development of (strict) anaerobic bacteria
  • Proprietary in vitro screening platforms
  • Proof of Concept studies via our in-house clinical unit